OraSure Technologies received BARDA contract for Rapid Oral Fluid Pan-SARS-Coronavirus in-home self-test
On Apr. 6, 2020, OraSure Technologies announced it had been awarded a $710,310 contract from the Biomedical Advanced…
USDA confirmed COVID-19 in a tiger in New York Zoo
On Apr. 6, 2020, the USDA confirmed SARS-CoV-2 (the virus that causes COVID-19 in humans) in one tiger…
Luminex received FDA Emergency Use Authorization for ARIES SARS-CoV-2 assay to detect virus responsible for COVID-19 disease
On Apr. 6, 2020, Luminex announced announced that the FDA has issued an Emergency Use Authorization for its…
VGXI supported rapid timeline to clinical testing for Coronavirus vaccine
On Apr. 6, 2020, VGXI, announced it had completed manufacturing and release of a DNA vaccine to combat…
Rice University established COVID-19 research fund
On Apr. 6, 2020, Rice University announced it had established a research accelerator fund to support projects –…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Non-Profit Research | Therapeutics
Mesa Biotech to develop molecular point-of-care diagnostic test for novel Coronavirus (COVID-19)
On Apr. 4, 2020, Mesa Biotech announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza…
University of Minnesota created on-site testing facility for COVID-19
On Apr. 3, 2020, the University of Minnesota announced it had created the stateﾒs fourth on-site testing facility…
COVID-19 | Diagnostics | FDA
BD, BioGX announced FDA Emergency Use Authorization for new COVID-19 diagnostic for use in U.S.
On Apr. 3, 2020, BD (Becton, Dickinson) and BioGX announced that the U.S. Food and Drug Administration (FDA)…
XBiotech and BioBridge Global collaborate on FDA program to develop potential COVID-19 antibody-based treatment
On Apr. 3, 2020, XBiotech and BioBridge Global announced a collaboration to participate in a FDA investigational program…
Trial drug significantly blocked early stages of COVID-19 in engineered human tissues
On Apr. 2, 2020, an international team led by University of British Columbia (UBC) researcher Dr. Josef Penninger…
University Hospital Basel, Switzerland transfused first two COVID-19 patients with INTERCEPT treated Coronavirus convalescent plasma
On Apr. 2, 2020, Cerus announced that the University Hospital Basel transfused the first two COVID-19 patients with…
Amgen and Adaptive Biotechnologies to develop a therapeutic to prevent or treat COVID-19
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
Vanda Pharma announced initiation of FDA approved clinical study of Tradipitant patients with severe COVID-19 pneumonia
On Apr. 2, 2020, Vanda Pharmaceuticals announced initiation of clinical study, ODYSSEY VLY-686-3501, in hospitalized patients with COVID-19….
Emergent BioSolutions partnered with U.S. Government to expedite development of plasma-derived therapy for COVID-19
On Apr. 2, 2020, Emergent BioSolutions announced it had entered into a formal partnership with the U.S. government…
COVID-19 | Therapeutics | WHO
CHF Solutions doubled production staff of Aquadex SmartFlow consoles due to hospital demand
On Apr. 2, 2020, CHF Solutions announced it has doubled the production staff that builds its next generation…
Collaborative effort brings new COVID-19 treatment approach to Western New York
On Apr. 2, 2020, Roswell Park Comprehensive Cancer Center and the University at Buffalo (UB) launched a collaborative…
Adaptive Biotechnologies and Amgen announced collaboration to address COVID-19 pandemic
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
ImmunityBio combined supercomputing power with Microsoft Azure to target infection -Doorway of the Coronavirus
On Apr. 1, 2020, ImmunityBio, a privately held immunotherapy company within the NantWorks ecosystem of companies, announced it…
Innovation Pharma received data supporting Brilacidinﾒs direct inhibition of SARS-CoV-2
On Apr. 1, 2020, Innovation Pharma it had received data supporting Brilacidinﾒs direct inhibition of SARS-CoV-2, the novel…
Vaxart provided update on its oral COVID-19 vaccine program
On Mar. 31, 2020, Vaxart announced it had produced five COVID-19 vaccine candidates for testing in its preclinical…
Chembio announced launch of DPP COVID-19 serological point-of-care test
On Mar. 31, 2020, Chembio Diagnostics announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test…
VBI Vaccines announced collaboration with National Research Council of Canada to develop pan-Coronavirus vaccine candidate
On Mar. 31, 2020, VBI Vaccines announced a collaboration with the National Research Council of Canada (NRC) to…
Bayer increased Germany’s COVID-19 analysis capacity by several thousand tests per day
On Mar. 30, 2020, Bayer announced it had made available more than 40 virus diagnostics devices from its…
Citizen scientists helped researchers design new drugs to combat COVID-19
On Mar. 30, 2020, Howard Hughes Medical Institute Investigator David Baker created new proteins tailor-made for specific tasks….
TGen, a genomic first responder, ramped up testing against COVID-19 coronavirus
On Mar. 30, 2020, the Translational Genomics Research Institute (TGen) announced that it had joined the world-wide effort…
Humanigen partnered with CTI for planned phase III study for lenzilumab for coronavirus treatment
On Mar. 30, 2020, Humanigen announced that the company had submitted an initial protocol synopsis to the FDA…
La Jolla Institute for Immunology hosted coronavirus immunotherapy clearinghouse
On Mar. 30, 2020, the La Jolla Institute for Immunology (LJI) announced it had been awarded a $1.73…
University of Minnesota researchers revealed how the novel coronavirus binds to human cells
On Mar. 30, 2020, researchers from the University of Minnesota broke new ground in understanding how SARS-CoV-2, the…
Bellerophon Therapeutics announced first patient treated with INOpulse inhaled nitric oxide therapy for COVID-19
On Mar. 30, 2020, Bellerophon Therapeutics announced that expanded access treatment with the INOpulse inhaled nitric oxide system…
Study documents widespread contamination of environment near patients with COVID-19
On Mar. 29, 2020, a study by UNMC/Nebraska Medicine/NSRI researchers provides new evidence of SARS-CoV-2 environmental contamination in…